ArticleCancers2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition.
Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, Thomas K Eigentler, Friedegund Meier, Peter Mohr, Tobias Pukrop, Alexander Roesch, Dirk Vordermark, Christina Wendl and 1 more
Abstract readPublished Erratum
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
11 authors.
Jessica C HasselSkin Cancer Center, Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0001-7575-6230 Lisa ZimmerDepartment of Dermatology, University Hospital Essen, 45147 Essen, Germany.
Thomas SickmannBristol-Myers Squibb GmbH & Co. KGaA, 80636 Munich, Germany.
Thomas K EigentlerDepartment of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.ORCID 0000-0003-0019-2770 Friedegund MeierDepartment of Dermatology, Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases, Faculty of Medicine and University Hospital Carl Gustav Carus, Technical University Dresden, 01062 Dresden, Germany.
Peter MohrDepartment of Dermatology, Elbe-Kliniken, 21614 Buxtehude, Germany.
Tobias PukropDepartment of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany.
Alexander RoeschDepartment of Dermatology, University Hospital Essen, 45147 Essen, Germany.
Dirk VordermarkDepartment for Radiation Oncology, Martin-Luther University Halle-Wittenberg, 06108 Halle, Germany.
Christina WendlDepartment of Radiology, University Hospital Regensburg, 93053 Regensburg, Germany.
Ralf GutzmerDepartment of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum, 32429 Minden, Germany.ORCID 0000-0001-7921-2820 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
There was an error regarding the affiliations for Alexander Roesch [...].
Identifiers
PMID41375089
PMCPMC12691055
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390